Universal Health Services Inc. (UHS) reported $18.35B of revenue for the twelve months ended Sep 30, 2026. That is up 8.0% from the year before. Revenue for fiscal 2025 was $17.36B.

Yes. Universal Health Services Inc. earned $1.46B in net income for the twelve months ended Sep 30, 2026, a net margin of 8.0%.

How much cash and debt does UHS have?

Universal Health Services Inc. reported $168.75M in cash and cash equivalents and $5.71B of debt on its most recent balance sheet in SEC filings.

How fast is UHS revenue growing?

Universal Health Services Inc.'s revenue changed +9.7% in fiscal 2025, to $17.36B. Its compound annual growth rate was +8.5% over 5 years and +5.9% over 10 years.

What is UHS free cash flow?

Universal Health Services Inc. generated $1.12B of free cash flow for the twelve months ended Sep 30, 2026, which is operating cash flow of $2.06B less capital expenditures.

What is UHS earnings per share?

Diluted earnings per share were $23.86 for the twelve months ended Sep 30, 2026, from SEC filings, restated for any stock split those filings show.

When did UHS last report financial results?

The latest statements here come from Universal Health Services Inc.'s 10-Q filed on Nov 6, 2026, covering the period ended Sep 30, 2026.

Financials · UHS

Universal Health Services Inc. (UHS) financials

For the twelve months ended Sep 30, 2026, Universal Health Services Inc. reported $18.35B of revenue and $1.46B of net income.

Revenue, TTM: $18.35B
Revenue growth, YoY: +8.0%
Net income, TTM: $1.46B
Net income growth, YoY: +6.3%
Net margin: 8.0%
Free cash flow, TTM: $1.12B
EPS, diluted, TTM: $23.86
EPS growth, YoY: +13.5%
Cash: $168.75M
Total debt: $5.71B
P/E: 7.88
P/S: 0.63
Market cap: $11.52B

Annual revenue$17.36B

FY2016FY2025

Annual net income$1.49B

FY2016FY2025

Annual free cash flow$849.25M

FY2016FY2025

UHS revenue and earnings growth

UHS revenueQ3 2026$4.73B

Quarter YoY: +5.3%
QoQ: +2.1%
FY YoY: +9.7%
5Y CAGR: +8.5%
10Y CAGR: +5.9%

UHS revenue was $4.73B in fiscal Q3 2026 (ended Sep 30, 2026), up 5.3% from a year earlier and up 2.1% from the prior quarter. For the full fiscal 2025 it was $17.36B, up 9.7% from fiscal 2024. Compound annual growth was +8.5% over 5 years and +5.9% over 10 years. It rose in 9 of the last 10 fiscal years. Fiscal 2025 is the highest of the 15 fiscal years on file.

UHS net incomeQ3 2026$308.68M

Quarter YoY: -17.2%
QoQ: -13.9%
FY YoY: +30.4%
5Y CAGR: +9.5%
10Y CAGR: +8.1%

UHS net income was $308.68M in fiscal Q3 2026 (ended Sep 30, 2026), down 17.2% from a year earlier and down 13.9% from the prior quarter. For the full fiscal 2025 it was $1.49B, up 30.4% from fiscal 2024. Compound annual growth was +9.5% over 5 years and +8.1% over 10 years. It rose in 9 of the last 10 fiscal years. Fiscal 2025 is the highest of the 15 fiscal years on file.

UHS EPSQ3 2026$5.22

Quarter YoY: -10.9%
QoQ: -12.7%
FY YoY: +37.3%
5Y CAGR: +16.0%
10Y CAGR: +13.1%

UHS diluted EPS was $5.22 in fiscal Q3 2026 (ended Sep 30, 2026), down 10.9% from a year earlier and down 12.7% from the prior quarter. For the full fiscal 2025 it was $23.10, up 37.3% from fiscal 2024. Compound annual growth was +16.0% over 5 years and +13.1% over 10 years.

UHS free cash flowQ3 2026$421.61M

Quarter YoY: +177.8%
QoQ: +95.5%
FY YoY: -24.4%
5Y CAGR: -12.2%
10Y CAGR: +2.1%

UHS free cash flow was $421.61M in fiscal Q3 2026 (ended Sep 30, 2026), up 177.8% from a year earlier and up 95.5% from the prior quarter. For the full fiscal 2025 it was $849.25M, down 24.4% from fiscal 2024. Compound annual growth was -12.2% over 5 years and +2.1% over 10 years. It rose in 6 of the last 10 fiscal years.

Export CSV

Income statement

Income statement
Line item	FY2025 Dec 31, 2025	FY2024 Dec 31, 2024	FY2023 Dec 31, 2023	FY2022 Dec 31, 2022	FY2021 Dec 31, 2021	FY2020 Dec 31, 2020	FY2019 Dec 31, 2019	FY2018 Dec 31, 2018	FY2017 Dec 31, 2017	FY2016 Dec 31, 2016
Revenue	$17.36B	$15.83B	$14.28B	$13.40B	$12.64B	$11.56B	$11.38B	$10.77B	$10.41B	$9.77B
Operating income	$1.99B	$1.68B	$1.18B	$1.00B	$1.36B	$1.36B	$1.22B	$1.18B	$1.28B	$1.28B
Interest expense	$156.07M	$186.11M	$206.67M	$126.89M	$83.67M	$106.28M	$162.73M	$154.96M	$145.17M	$125.05M
Pre-tax income	$1.97B	$1.50B	$940.43M	$866.26M	$1.29B	$1.25B	$1.07B	$1.03B	$1.14B	$1.16B
Income tax	$460.96M	$334.83M	$221.12M	$209.28M	$305.68M	$299.29M	$238.79M	$236.64M	$363.70M	$409.19M
Net income	$1.49B	$1.14B	$717.79M	$675.61M	$991.59M	$943.95M	$814.85M	$779.71M	$752.30M	$702.41M
EPS, basic	$23.42	$17.16	$10.35	$9.23	$11.99	$11.06	$9.16	$8.35	$7.86	$7.22
EPS, diluted	$23.10	$16.82	$10.23	$9.14	$11.82	$10.99	$9.13	$8.31	$7.81	$7.14
Diluted shares	64.5M	67.9M	70.1M	73.8M	83.7M	85.6M	89.0M	93.8M	96.3M	98.4M

Balance sheet

Balance sheet
Line item	FY2025 Dec 31, 2025	FY2024 Dec 31, 2024	FY2023 Dec 31, 2023	FY2022 Dec 31, 2022	FY2021 Dec 31, 2021	FY2020 Dec 31, 2020	FY2019 Dec 31, 2019	FY2018 Dec 31, 2018	FY2017 Dec 31, 2017	FY2016 Dec 31, 2016
Cash and equivalents	$137.80M	$125.98M	$119.44M	$102.82M	$115.30M	$1.22B	$61.27M	$105.22M	$74.42M	$33.75M
Receivables	$2.60B	$2.18B	$2.24B	$2.02B	$1.75B	$1.73B	$1.56B	$1.51B	$1.50B	$1.44B
Current assets	$3.41B	$2.82B	$2.81B	$2.54B	$2.26B	$3.28B	$1.92B	$1.94B	$1.80B	$1.68B
Goodwill	$3.99B	$3.93B	$3.93B	$3.91B	$3.96B	$3.88B	$3.87B	$3.84B	$3.83B	$3.78B
Total assets	$15.53B	$14.47B	$13.97B	$13.49B	$13.09B	$13.48B	$11.67B	$11.27B	$10.76B	$10.32B
Current liabilities	$3.24B	$2.21B	$2.01B	$1.91B	$1.98B	$2.48B	$1.56B	$1.45B	$1.85B	$1.32B
Short-term debt	$748.16M	$40.06M	$126.69M	$81.45M	$48.41M	$332.00M	$87.55M	$63.45M	$545.62M	$105.89M
Long-term debt	$4.00B	$4.46B	$4.79B	$4.73B	$4.14B	$3.52B	$3.90B	$3.94B	$3.49B	$4.03B
Total debt	$4.75B	$4.50B	$4.91B	$4.81B	$4.19B	$3.86B	$3.98B	$4.00B	$4.04B	$4.14B
Total liabilities	$8.19B	$7.72B	$7.77B	$7.53B	$6.90B	$7.07B	$6.09B	$5.80B	$5.71B	$5.72B
Shareholders' equity	$7.28B	$6.75B	$6.20B	$5.97B	$6.19B	$6.40B	$5.58B	$5.47B	$5.05B	$4.60B

Cash flow

Cash flow
Line item	FY2025 Dec 31, 2025	FY2024 Dec 31, 2024	FY2023 Dec 31, 2023	FY2022 Dec 31, 2022	FY2021 Dec 31, 2021	FY2020 Dec 31, 2020	FY2019 Dec 31, 2019	FY2018 Dec 31, 2018	FY2017 Dec 31, 2017	FY2016 Dec 31, 2016
Operating cash flow	$1.86B	$2.07B	$1.27B	$996.02M	$883.70M	$2.36B	$1.44B	$1.27B	$1.25B	$1.33B
Capital expenditures	$1.02B	$943.81M	$743.05M	$734.00M	$855.66M	$731.31M	$634.10M	$664.96M	$557.51M	$519.94M
Free cash flow	$849.25M	$1.12B	$524.74M	$262.02M	$28.04M	$1.63B	$804.37M	$609.78M	$690.08M	$813.90M
Investing cash flow	-$1.07B	-$911.11M	-$763.27M	-$647.30M	-$914.47M	-$802.56M	-$688.41M	-$747.25M	-$684.73M	-$1.16B
Financing cash flow	-$749.73M	-$1.14B	-$493.94M	-$318.40M	-$1.07B	-$384.86M	-$845.04M	-$492.20M	-$519.15M	-$171.17M
Dividends paid	$51.27M	$53.35M	$55.48M	$58.45M	$65.90M	$17.34M	$53.00M	$37.34M	$38.21M	$38.88M
Share repurchases	$967.95M	$670.75M	$547.36M	$832.92M	$1.22B	$206.72M	$770.50M	$397.43M	$364.40M	$353.38M
Stock-based compensation	$95.69M	$99.35M	$87.72M	$85.38M	$73.69M	$65.84M	$69.43M	$66.58M	$56.74M	$48.11M
Depreciation and amortization	$618.74M	$584.83M	$568.04M	$581.86M	$533.21M	$510.49M	$490.39M	$453.05M	$447.76M	$416.61M

Key ratios

Key ratios
Line item	FY2025 Dec 31, 2025	FY2024 Dec 31, 2024	FY2023 Dec 31, 2023	FY2022 Dec 31, 2022	FY2021 Dec 31, 2021	FY2020 Dec 31, 2020	FY2019 Dec 31, 2019	FY2018 Dec 31, 2018	FY2017 Dec 31, 2017	FY2016 Dec 31, 2016
Revenue growth, YoY	9.7%	10.8%	6.6%	6.0%	9.4%	1.6%	5.6%	3.5%	6.6%	-0.2%
Net income growth, YoY	30.4%	59.1%	6.2%	-31.9%	5.0%	15.8%	4.5%	3.6%	7.1%	3.2%
EPS growth, YoY	37.3%	64.4%	11.9%	-22.7%	7.6%	20.4%	9.9%	6.4%	9.4%	5.6%
Operating margin	11.5%	10.6%	8.2%	7.5%	10.8%	11.8%	10.7%	10.9%	12.3%	13.1%
Net margin	8.6%	7.2%	5.0%	5.0%	7.8%	8.2%	7.2%	7.2%	7.2%	7.2%
Free cash flow margin	4.9%	7.1%	3.7%	2.0%	0.2%	14.1%	7.1%	5.7%	6.6%	8.3%
Return on equity	20.5%	16.9%	11.6%	11.3%	16.0%	14.7%	14.6%	14.3%	14.9%	15.3%
Return on assets	9.6%	7.9%	5.1%	5.0%	7.6%	7.0%	7.0%	6.9%	7.0%	6.8%
Current ratio	1.05	1.27	1.40	1.33	1.14	1.32	1.23	1.34	0.97	1.28
Debt to equity	0.65	0.67	0.79	0.81	0.68	0.60	0.71	0.73	0.80	0.90

Income statement

Income statement
Line item	Q3 2026 Sep 30, 2026	Q2 2026 Jun 30, 2026	Q1 2026 Mar 31, 2026	Q4 2025* Dec 31, 2025	Q3 2025 Sep 30, 2025	Q2 2025 Jun 30, 2025	Q1 2025 Mar 31, 2025	Q4 2024* Dec 31, 2024	Q3 2024 Sep 30, 2024	Q2 2024 Jun 30, 2024	Q1 2024 Mar 31, 2024	Q4 2023* Dec 31, 2023
Revenue	$4.73B	$4.64B	$4.50B	$4.49B	$4.50B	$4.28B	$4.10B	$4.11B	$3.96B	$3.91B	$3.84B	$3.70B
Operating income	$454.45M	$516.67M	$502.86M	$517.23M	$521.69M	$500.27M	$454.82M	$472.49M	$384.17M	$436.40M	$388.76M	$331.20M
Interest expense	$56.28M	$39.91M	$37.13M	$42.22M	$38.43M	$35.36M	$40.06M	$39.72M	$44.66M	$48.90M	$52.83M	$53.59M
Pre-tax income	$413.91M	$479.13M	$469.12M	$581.44M	$496.89M	$473.38M	$420.43M	$438.31M	$341.53M	$382.01M	$336.09M	$281.12M
Income tax	$100.58M	$114.54M	$110.44M	$133.60M	$117.78M	$110.77M	$98.80M	$101.26M	$75.62M	$87.68M	$70.26M	$61.50M
Net income	$308.68M	$358.45M	$348.68M	$445.94M	$372.96M	$353.22M	$316.68M	$332.40M	$258.71M	$289.15M	$261.83M	$216.38M
EPS, basic	$5.25	$6.01	$5.71	$7.14	$5.92	$5.49	$4.87	$5.05	$3.89	$4.32	$3.90	$3.18
EPS, diluted	$5.22	$5.98	$5.65	$7.01	$5.86	$5.43	$4.80	$4.94	$3.80	$4.26	$3.82	$3.13
Diluted shares	59.1M	59.9M	61.7M	-	63.7M	65.0M	66.0M	-	68.1M	67.9M	68.5M	-

Balance sheet

Balance sheet
Line item	Q3 2026 Sep 30, 2026	Q2 2026 Jun 30, 2026	Q1 2026 Mar 31, 2026	Q4 2025* Dec 31, 2025	Q3 2025 Sep 30, 2025	Q2 2025 Jun 30, 2025	Q1 2025 Mar 31, 2025	Q4 2024* Dec 31, 2024	Q3 2024 Sep 30, 2024	Q2 2024 Jun 30, 2024	Q1 2024 Mar 31, 2024	Q4 2023* Dec 31, 2023
Cash and equivalents	$168.75M	$138.80M	$119.03M	$137.80M	$112.89M	$137.59M	$126.75M	$125.98M	$106.08M	$128.79M	$112.09M	$119.44M
Receivables	$2.81B	$2.80B	$2.75B	$2.60B	$2.59B	$2.30B	$2.41B	$2.18B	$2.21B	$2.16B	$2.30B	$2.24B
Current assets	$3.68B	$3.68B	$3.50B	$3.41B	$3.26B	$2.99B	$3.08B	$2.82B	$2.80B	$2.74B	$2.87B	$2.81B
Goodwill	$4.74B	$3.98B	$3.98B	$3.99B	$3.99B	$3.98B	$3.95B	$3.93B	$3.97B	$3.94B	$3.93B	$3.93B
Total assets	$17.19B	$15.94B	$15.68B	$15.53B	$15.34B	$14.99B	$14.88B	$14.47B	$14.35B	$14.07B	$14.05B	$13.97B
Current liabilities	$2.69B	$3.30B	$3.24B	$3.24B	$3.16B	$2.32B	$2.33B	$2.21B	$2.01B	$2.15B	$2.08B	$2.01B
Short-term debt	$79.81M	$771.91M	$756.24M	$748.16M	$740.19M	$40.90M	$40.41M	$40.06M	$38.35M	$127.51M	$127.48M	$126.69M
Long-term debt	$5.63B	$4.08B	$3.95B	$4.00B	$3.95B	$4.54B	$4.61B	$4.46B	$4.62B	$4.42B	$4.73B	$4.79B
Total debt	$5.71B	$4.85B	$4.71B	$4.75B	$4.69B	$4.58B	$4.65B	$4.50B	$4.66B	$4.54B	$4.86B	$4.91B
Total liabilities	$9.52B	$8.35B	$8.15B	$8.19B	$8.11B	$7.90B	$8.00B	$7.72B	$7.67B	$7.52B	$7.74B	$7.77B
Shareholders' equity	$7.60B	$7.58B	$7.53B	$7.28B	$7.23B	$7.09B	$6.87B	$6.75B	$6.68B	$6.55B	$6.31B	$6.20B

Cash flow

Cash flow
Line item	Q3 2026 Sep 30, 2026	Q2 2026 Jun 30, 2026	Q1 2026 Mar 31, 2026	Q4 2025* Dec 31, 2025	Q3 2025 Sep 30, 2025	Q2 2025 Jun 30, 2025	Q1 2025 Mar 31, 2025	Q4 2024* Dec 31, 2024	Q3 2024 Sep 30, 2024	Q2 2024 Jun 30, 2024	Q1 2024 Mar 31, 2024	Q4 2023* Dec 31, 2023
Operating cash flow	$636.56M	$443.30M	$401.63M	$574.69M	$380.68M	$548.98M	$360.05M	$658.44M	$332.98M	$679.28M	$396.41M	$452.43M
Capital expenditures	$214.94M	$227.63M	$217.16M	$281.22M	$228.89M	$266.01M	$239.03M	$245.94M	$247.93M	$241.39M	$208.54M	$206.39M
Free cash flow	$421.61M	$215.67M	$184.47M	$293.47M	$151.79M	$282.96M	$121.02M	$412.49M	$85.05M	$437.89M	$187.87M	$246.04M
Investing cash flow	-$1.21B	-$234.23M	-$197.58M	-$223.97M	-$269.41M	-$305.94M	-$271.30M	-$207.99M	-$265.64M	-$242.84M	-$194.64M	-$238.85M
Financing cash flow	$605.73M	-$189.49M	-$221.89M	-$296.13M	-$134.52M	-$227.65M	-$91.42M	-$426.76M	-$89.65M	-$419.52M	-$208.95M	-$182.32M
Dividends paid	$11.79M	$11.79M	$12.97M	$12.37M	$12.47M	$12.90M	$13.53M	$13.04M	$13.30M	$13.40M	$13.60M	$13.52M
Share repurchases	$245.26M	$320.75M	$163.85M	$352.01M	$237.40M	$155.16M	$223.38M	$250.17M	$182.60M	$95.90M	$142.08M	$162.02M
Stock-based compensation	$26.36M	$22.91M	$22.50M	$25.10M	$24.88M	$24.11M	$21.59M	$26.62M	$26.57M	$26.53M	$19.63M	$22.02M
Depreciation and amortization	$174.84M	$167.34M	$155.43M	$163.33M	$155.06M	$152.00M	$148.34M	$146.78M	$149.57M	$147.48M	$141.00M	$145.48M

Key ratios

Key ratios
Line item	Q3 2026 Sep 30, 2026	Q2 2026 Jun 30, 2026	Q1 2026 Mar 31, 2026	Q4 2025* Dec 31, 2025	Q3 2025 Sep 30, 2025	Q2 2025 Jun 30, 2025	Q1 2025 Mar 31, 2025	Q4 2024* Dec 31, 2024	Q3 2024 Sep 30, 2024	Q2 2024 Jun 30, 2024	Q1 2024 Mar 31, 2024	Q4 2023* Dec 31, 2023
Revenue growth, YoY	5.3%	8.3%	9.6%	9.1%	13.4%	9.6%	6.7%	11.1%	11.2%	10.1%	10.8%	7.4%
Net income growth, YoY	-17.2%	1.5%	10.1%	34.2%	44.2%	22.2%	20.9%	53.6%	54.9%	68.8%	60.5%	23.8%
EPS growth, YoY	-10.9%	10.1%	17.7%	41.9%	54.2%	27.5%	25.7%	57.8%	58.3%	76.0%	67.5%	29.3%
Operating margin	9.6%	11.1%	11.2%	11.5%	11.6%	11.7%	11.1%	11.5%	9.7%	11.2%	10.1%	8.9%
Net margin	6.5%	7.7%	7.8%	9.9%	8.3%	8.2%	7.7%	8.1%	6.5%	7.4%	6.8%	5.8%
Free cash flow margin	8.9%	4.7%	4.1%	6.5%	3.4%	6.6%	3.0%	10.0%	2.1%	11.2%	4.9%	6.6%
Current ratio	1.37	1.12	1.08	1.05	1.03	1.29	1.32	1.27	1.39	1.28	1.38	1.40
Debt to equity	0.75	0.64	0.63	0.65	0.65	0.65	0.68	0.67	0.70	0.69	0.77	0.79

Source: XBRL data Universal Health Services Inc. files with the SEC, latest filing dated Nov 6, 2026 (see filings on SEC EDGAR). Provided for information only, not investment advice. Check the filing before relying on a number.

* Worked out from the filings rather than stated in them: Q4 is the full year less the first nine months.

Per-share figures are as filed. The filings show no stock split in these periods.

EPS growth is left out where the share count moved enough to suggest a split the filings do not show. Growth rates need a positive starting figure. CAGR is compound annual growth between fiscal years. The CSV holds every period on file, in full figures, from the same SEC filings.

UHS peers

Company	Revenue	Growth	Net income	Net margin	Market cap
UHS	$18.35B	+8.0%	$1.46B	8.0%	$11.52B
HCAHCA Healthcare Inc.	$78.70B	+5.8%	$6.78B	8.6%	$103.40B
THCTenet Healthcare Corporation	$22.15B	+6.2%	$2.90B	13.1%	$22.55B
EHCEncompass Health Corporation	$6.34B	+9.4%	$644.40M	10.2%	$13.50B
ENSGThe Ensign Group Inc.	$5.67B	+17.5%	$399.12M	7.0%	$10.56B
PACSPACS Group Inc.	$5.71B	+11.0%	$277.58M	4.9%	$7.87B
NHCNational HealthCare Corporation	$1.58B	+5.6%	$115.13M	7.3%	$3.27B
SGRYSurgery Partners Inc.	$3.37B	+4.0%	-$88.60M	-2.6%	$3.04B
MDPediatrix Medical Group Inc.	$1.96B	+1.9%	$150.09M	7.7%	$2.44B

UHS FAQ

8 questions

What is UHS revenue?
Universal Health Services Inc. (UHS) reported $18.35B of revenue for the twelve months ended Sep 30, 2026. That is up 8.0% from the year before. Revenue for fiscal 2025 was $17.36B.
Is UHS profitable?
Yes. Universal Health Services Inc. earned $1.46B in net income for the twelve months ended Sep 30, 2026, a net margin of 8.0%.
How much cash and debt does UHS have?
Universal Health Services Inc. reported $168.75M in cash and cash equivalents and $5.71B of debt on its most recent balance sheet in SEC filings.
How fast is UHS revenue growing?
Universal Health Services Inc.'s revenue changed +9.7% in fiscal 2025, to $17.36B. Its compound annual growth rate was +8.5% over 5 years and +5.9% over 10 years.
What is UHS free cash flow?
Universal Health Services Inc. generated $1.12B of free cash flow for the twelve months ended Sep 30, 2026, which is operating cash flow of $2.06B less capital expenditures.
What is UHS earnings per share?
Diluted earnings per share were $23.86 for the twelve months ended Sep 30, 2026, from SEC filings, restated for any stock split those filings show.
When did UHS last report financial results?
The latest statements here come from Universal Health Services Inc.'s 10-Q filed on Nov 6, 2026, covering the period ended Sep 30, 2026.
Where does this UHS financial data come from?
Quantisnow builds these statements from the structured XBRL data Universal Health Services Inc. files with the SEC. It is provided for information only and is not investment advice.